Fig. 1: Event-free and overall survival, and cumulative incidences of relapse, non-relapse mortality, acute GVHD grades II-IV, and chronic GVHD of any severity by donor type. | Leukemia

Fig. 1: Event-free and overall survival, and cumulative incidences of relapse, non-relapse mortality, acute GVHD grades II-IV, and chronic GVHD of any severity by donor type.

From: Young unrelated donors confer a survival advantage for patients with myeloid malignancies compared to older siblings

Fig. 1

Kaplan-Meier curves for event-free survival and overall survival and cumulative incidence plots for relapse, non-relapse mortality, acute GVHD grades II–IV and chronic GVHD comparing patients with matched sibling donors versus HLA-compatible unrelated donors matched for HLA-A, -B, -C, -DRB1, and -DQB1.

Back to article page